A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors
A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors
Recruiting · NCT05907980 · Registry updated 2026-07-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors | Solid Tumor | Recruiting | Phase 1 | 2026-07-28 | NCT05907980 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chugai Pharmaceutical | 25 |
14 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Aichi Cancer Center | Nagoya | Japan | 23 |
| Kanagawa cancer center | Yokohama | Japan | 39 |
| Kansai Medical University Hospital | Hirakata-shi | Japan | 15 |
| Kindai University Hospital | Sakai-shi | Japan | 6 |
| MD Anderson Cancer Center | Houston | United States | 589 |
| National Cancer Center Hospital | Chuo-ku | Japan | 67 |
| National Cancer Center Hospital East | Kashiwa-shi | Japan | 37 |
| NEXT Oncology | Fairfax | United States | 31 |
| Osaka International Cancer Institute | Osaka | Japan | 16 |
| Rhode Island Hospital | Providence | United States | 229 |
| Scri Oncology Partners | Nashville | United States | 156 |
| Shizuoka Cancer Center | Nagaizumi-chō | Japan | 6 |
| The Cancer Institute Hospital of JFCR | Koto-ku | Japan | 25 |
| University of Pennsylvania Perelman Center for Advanced Medicine | Philadelphia | United States | 8 |